Alps Advisors Inc Syros Pharmaceuticals, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$3.26 - $4.66 $247,447 - $353,712	-75,904 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.08 - $5.66 $22,725 - $31,526	-5,570 Reduced 6.84%	75,904 $339,000
Q2 2021 Aug 11, 2021	SELL	$5.01 - $7.48 $150,480 - $224,669	-30,036 Reduced 26.94%	81,474 $444,000
Q1 2021 May 07, 2021	BUY	$7.19 - $14.95 $207,043 - $430,500	28,796 Added 34.81%	111,510 $834,000
Q4 2020 Feb 03, 2021	BUY	$6.66 - $14.66 $162,210 - $357,058	24,356 Added 41.74%	82,714 $897,000
Q3 2020 Nov 04, 2020	SELL	$8.69 - $14.47 $34,490 - $57,431	-3,969 Reduced 6.37%	58,358 $516,000
Q2 2020 Aug 05, 2020	BUY	$5.21 - $11.03 $324,723 - $687,466	62,327 New	62,327 $664,000
Q2 2019 Aug 07, 2019	SELL	$5.5 - $9.75 $447,078 - $792,548	-81,287 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$5.51 - $9.59 $19,389 - $33,747	3,519 Added 4.52%	81,287 $743,000
Q4 2018 Feb 04, 2019	BUY	$5.55 - $11.34 $101,093 - $206,558	18,215 Added 30.59%	77,768 $433,000
Q3 2018 Oct 25, 2018	BUY	$9.74 - $12.92 $119,607 - $158,657	12,280 Added 25.98%	59,553 $709,000
Q2 2018 Aug 02, 2018	BUY	$10.16 - $13.65 $480,293 - $645,276	47,273 New	47,273 $483,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.